Edgestream Partners’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,474
Closed -$965K 1050
2026
Q1
$965K Buy
+7,474
New +$1.07M 0.03% 640
2025
Q1
Sell
-4,374
Closed -$679K 930
2024
Q4
$679K Buy
+4,374
New +$740K 0.03% 636
2024
Q3
Sell
-1,947
Closed -$231K 952
2024
Q2
$231K Buy
+1,947
New +$205K 0.01% 787
2024
Q1
Sell
-25,694
Closed -$2.56M 905
2023
Q4
$2.56M Buy
25,694
+7,362
+40% +$720K 0.18% 180
2023
Q3
$2.18M Buy
+18,332
New +$2.74M 0.17% 171
2022
Q4
Sell
-12,020
Closed -$1.81M 561
2022
Q3
$1.81M Sell
12,020
-8,344
-41% -$1.39M 0.14% 207
2022
Q2
$3.35M Buy
+20,364
New +$3.92M 0.26% 127
2022
Q1
Sell
-5,963
Closed -$1.42M 581
2021
Q4
$1.42M Buy
5,963
+4,957
+493% +$1.16M 0.09% 269
2021
Q3
$235K Buy
+1,006
New +$211K 0.01% 452

Other funds holding ICUI

Edgestream Partners's ICUI Position: Q2 2026 in Review

Edgestream Partners sold out of ICU Medical (ICUI) in Q2 2026, closing a stake of 7,474 shares — an estimated $965K sold.

Edgestream Partners first reported a position in ICUI in Q3 2021 and held it in 9 quarters. The position peaked at $3.35M in Q2 2022. 288 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.

  • Edgestream Partners reported no remaining ICU Medical position as of Q2 2026 after selling out during the quarter.
  • Edgestream Partners sold 7,474 ICU Medical shares in Q2 2026, an estimated $965K.
  • Edgestream Partners first reported a position in ICU Medical in Q3 2021 and held it in 9 quarters.
  • Edgestream Partners's ICU Medical position peaked at $3.35M in Q2 2022.
  • 288 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.